ArticleJournal of translational medicine2024

Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I.

Haiyan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.